Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name MIR222HG
   Synonyms Lnc-Ang362
   Region GRCh38_X:45745211-45770274    Sequence
   Ensembl ENSG00000270069
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name prostate cancer
   ICD-0-3 C61.9  
   Methods qPCR, luciferase reporter assay, RIP, in vitro knockdown etc.
   Sample cell line (LNCaP, LNCaP-Abl), PCa tumor tissues
   Expression Pattern up-regulated
   Function Description

Upon promoter activation, a set of polyadenylated long non-coding RNA (lncRNA) MIR222HGs was transcribed from this promoter region. Over-expression of these MIR222HGs increased androgen-independent cell growth and repressed the expression of androgen receptor-regulated dihydrotestosterone (DHT)-induced KLK3, TMPRSS2, and FKBP5 in HSPC LNCaP cells, hallmarks of the CRPC phenotype. Clinically, increased expression of MIR222HG is associated with PCa progression to CRPC.MIR222HG may potentially affect miR-mediated expression silencing, subsequently leading to AR reprogramming. Our study highlights an essential role of a non-coding RNA in CRPC development and that differential activation of a single promoter can up-regulate two different types of non-coding RNAs, miR-221/222 and lncRNA MIR222HG, in CRPC.

   Pubmed ID 29540675
   Year 2018
   Title Expression of lncRNA MIR222HG co tra Source Oncogenesis SO 2018 Mar 13 7 3 30[PMIDT29540675]
   External Links
   Links for  MIR222HG GenBank       HGNC       lncrnadb       Noncode
   Links for  prostate cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.